Controversies in Migraine Management

CTAF
July 11, 2014 10:00AM-4:00PM (PST)

Sheraton Gateway Hotel, Los Angeles, CA

CTAF examined various treatment options for migraine headaches. CTAF's review included evidence on the use of Botox for prevention and on the use of opioids for treatment in the emergency room. Also briefly reviewed were a new device for the prevention of migraines (Cefaly) and one for the treatment of migraines (SpringTMS by eNeura). CTAF’s public deliberation of the evidence will provide clarity and guidance to clinicians, insurers, and patients confronted with decisions on treatment of migraines.

Key Dates

Associated Materials

06/13/2014

06/13/2014

07/11/2014

07/11/2014

07/18/2014

Public comments received on the Draft Evidence Report.


08/19/2014
Action Guide For Patients

08/19/2014
Action Guide For Clinicians

08/19/2014
Action Guide For Payers and Policymakers

Other Materials